San Francisco, United States
Brightseed, founded in 2017, is a cutting-edge company at the intersection of A.I. and biosciences, based in the United States. Dubbed as "The Bioactives Company," it leverages its proprietary A.I. Forager® to accelerate the discovery and validation of bioactives, condensing processes from years to months. This innovative technology allows Brightseed to forge novel connections between nature and human health, facilitating transformative solutions in bioactive discovery.
The company's goal is to enhance human well-being through partnerships across the consumer health spectrum, producing clinically validated bioactives integrated into products by leading brands in dietary supplements, food & beverage CPG, specialty nutrition, and medical food sectors.
Brightseed recently secured a $1.60M grant from the Bill & Melinda Gates Foundation as a testament to its groundbreaking work, positioning it as a compelling investment opportunity in the AI, Biotechnology, Health and Wellness, and Pharmaceutical sectors.
